Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assessment of the Mouth01:26

Assessment of the Mouth

A thorough mouth assessment, including inspection and palpation of the lips, gums, tongue, tonsils, uvula, and pharynx, is crucial in detecting potential health issues. Diseases ranging from oral cancer to systemic conditions like diabetes could be identified early through careful oral examination. This article provides a detailed guide on conducting a comprehensive mouth assessment.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

General dentists' approach to dental management of patients taking anticoagulants: a national survey-based assessment: pre- and post-procedure practice.

Oral surgery, oral medicine, oral pathology and oral radiology·2026
Same author

Longitudinal assessment and predictors of subjective taste change after hematopoietic cell transplantation (HCT).

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

A Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology Clinical Practice Statement: Management of social eating and drinking challenges in adults with cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Photobiomodulation Therapy in the Management of Orofacial Neuropathic Pain-WALT Position Paper 2026.

Journal of clinical medicine·2026
Same author

Taste disorders in cancer patients and current therapeutic approaches: a narrative review of an understudied topic in supportive care.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Patient-Reported Oral Symptoms and Their Impact on Well-Being After Haematopoietic Cell Transplantation.

Oral diseases·2025

Related Experiment Video

Updated: Jun 13, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

Oral mucositis.

Judith E Raber-Durlacher1, Sharon Elad, Andrei Barasch

  • 1Department of Periodontology, Academic Centre of Dentistry, Louwesweg 1, 1066 EA, Amsterdam, The Netherlands. jraber@worldonline.n

Oral Oncology
|April 21, 2010
PubMed
Summary
This summary is machine-generated.

Oral mucositis, a common side effect of cancer therapy, causes significant patient distress. Better understanding of its causes and risk factors is crucial for improving patient management and pain relief.

More Related Videos

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
08:02

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice

Published on: February 18, 2015

Related Experiment Videos

Last Updated: Jun 13, 2026

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
07:05

Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

Published on: May 12, 2019

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
08:02

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice

Published on: February 18, 2015

Area of Science:

  • Oncology
  • Cancer Therapy
  • Patient Care

Background:

  • Mucosal damage, specifically oral mucositis, is a frequent adverse effect of cancer radiotherapy and chemotherapy.
  • Its prevalence ranges from 10% to 100%, significantly impacting patient quality of life and treatment adherence.
  • Current management strategies and pain relief for oral mucositis remain inadequate despite clinical guidelines.

Purpose of the Study:

  • To review the pathobiology, risk factors, impact, and current management of oral mucositis.
  • To highlight the need for improved understanding of mucositis pathogenesis and individual risk factors.
  • To identify opportunities for enhancing patient management strategies for this condition.

Main Methods:

  • Literature review of recent evidence on oral mucositis.
  • Discussion of pathobiology and risk factors.
  • Analysis of current management strategies and their limitations.

Main Results:

  • Oral mucositis presents a significant challenge in oncology due to its high prevalence and inadequate management options.
  • Despite advancements, effective treatments for mucositis and associated oropharyngeal pain are still lacking.
  • Knowledge gaps in pathogenesis and individual risk factors hinder optimal patient care.

Conclusions:

  • Further research into the pathogenesis and individual risk factors of oral mucositis is essential.
  • Improved understanding will pave the way for more effective management strategies and better patient outcomes.
  • Addressing these knowledge gaps is critical for alleviating patient suffering from cancer therapy-induced mucosal damage.